Neurogene raises USD 68.5 Million for rare neurological diseases Neurogene netted USD 68.5 million to advance multiple gene therapy programs in its series A round. The…
Feb 14 
Month: February 2019
Feb 13 
The antidepressant drug gets support from FDA
The hallucinogenic party drug, ketamine has passed the final problem for going into the clinical stage as an antidepressant. The US Food and Drug Administration (FDA),…
Feb 11 
Raynaud’s Disease -A debilitating condition
Raynaud’s Disease (RD), also called Raynaud’s phenomenon, is a rare disorder of the blood vessels. The symptoms include when one is feeling cold or feeling stressed in some areas…
Feb 8 
Feb 7 
The Business Cocktail
Genentech remunerates Xencor USD 120 Million for global rights Genentech has remunerated USD 120 million upfront to have global rights to IL-15 cytokine therapeutics in preclinical development at…
Feb 6 
Relation between gut microbes and depression bolstered
Relations between the central nervous system and the trillions of bacteria in the gut are being targeted for research. What we know so far is based…
Feb 4 
Myasthenia Gravis
To get a free sample report, click the link: https://www.delveinsight.com/report-store/myasthenia-gravis-market-insight-epidemiology-and-market-forecast
Feb 1 
Neuroendocrine Tumors (NETs)
For sample report, click the link below : https://www.delveinsight.com/report-store/neuroendocrine-tumors-nets-market-insights-epidemiology-and-market-forecast
